NewsBenzingaAC Immune anuncia resultados de seguridad e inmunogenicidad hasta la semana 100 en la parte 1 de VacSYn, su ensayo de fase 2 de ACI-7104 en pacientes con enfermedad de Parkinson en etapa temprana: Se cumplieron todos los puntos finales primarios... AC Immune anuncia resultados de seguridad e inmunogenicidad hasta la semana 100 en la parte 1 de VacSYn, su ensayo de fase 2 de ACI-7104 en pacientes con enfermedad de Parkinson en etapa temprana: Se cumplieron todos los puntos finales primarios... Benzinga 2026.09.23 11:05 (GMT+0) Open on Benzinga Other news Why Is IREN Stock Surging Monday? Cleveland-Cliffs Q3 2026 Earnings Call Transcript On Sunday October 18, 2026 TeraWulf CEO Paul Prager Posted On X "$WULF is NOT a neocloud. $WULF IS an energy infrastructure company. We match long term investment grade energy supply with long term HPC/AI off-take. We finance our projects competitively... Cosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70% Jefferies Maintains Hold on Kinetik Holdings, Lowers Price Target to $54 Stephens & Co. Maintains Equal-Weight on Regions Financial, Lowers Price Target to $30
On Sunday October 18, 2026 TeraWulf CEO Paul Prager Posted On X "$WULF is NOT a neocloud. $WULF IS an energy infrastructure company. We match long term investment grade energy supply with long term HPC/AI off-take. We finance our projects competitively...
